<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04672538</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY20100012</org_study_id>
    <nct_id>NCT04672538</nct_id>
  </id_info>
  <brief_title>Fontan Physiology Ventilation Strategy</brief_title>
  <official_title>Impact of Fontan Ventilation Strategy on Cardiac Output: An Invasive Physiologic Cross-over Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the different tidal volume (Vt) strategies during a cardiac&#xD;
      catheterization procedure to determine whether or not low or high Vt have an impact on&#xD;
      cardiac output.&#xD;
&#xD;
      Research question: While maintaining the same minute ventilation/PaCO2, does higher Vt (10&#xD;
      cc/kg)/lower rate vs. lower Vt (6 cc/kg)/higher rate (maintaining consistent PEEP) result in&#xD;
      improved cardiac output?&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The trial will be a randomized crossover design. The study cohort will be randomized (50/50)&#xD;
      to begin with either low Vt or high Vt ventilation. After achieving steady state, initial&#xD;
      cardiac output measurements will be made using a measured oxygen consumption (VO2) and the&#xD;
      Fick principle, per routine clinical protocol. Following baseline assessment of cardiac&#xD;
      output and hemodynamics (which is standard of care for all catheterization procedures),&#xD;
      participants will be transitioned to the alternative ventilation modality (high Vt or low&#xD;
      Vt). After a 5-minute equilibration period, oxygen saturations and VO2 measurements will be&#xD;
      re-acquired, to determine cardiac output and hemodynamics in this second state.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The trial will be a randomized crossover design.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Randomized cross over</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac Output</measure>
    <time_frame>Measurements will occur at the 5-minute equilibration period into the ventilation strategy.</time_frame>
    <description>The investigators will assess cardiac output using the Fink principle for each arm of randomization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulmonary blood flow</measure>
    <time_frame>Measurements will occur at the 5-minute equilibration period into the ventilation strategy.</time_frame>
    <description>The investigators will compare blood flow in both arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systemic blood pressure</measure>
    <time_frame>Measurements will occur at the 5-minute equilibration period into the ventilation strategy.</time_frame>
    <description>The investigators will assess the vital sign in both intervention arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary arterial pressure</measure>
    <time_frame>Measurements will occur at the 5-minute equilibration period into the ventilation strategy.</time_frame>
    <description>The investigators will assess pressures in both intervention arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary vascular resistance</measure>
    <time_frame>Measurements will occur at the 5-minute equilibration period into the ventilation strategy.</time_frame>
    <description>Completed using pulmonary vascular resistance (PVR) equation from measurements obtained during the cardiac catheterization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systemic vascular resistance</measure>
    <time_frame>Measurements will occur at the 5-minute equilibration period into the ventilation strategy.</time_frame>
    <description>This will be calculated using appropriate equations using measurement obtained during catheterization procedure.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Anesthesia</condition>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>Low transition to High Vt protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm of the study will begin with lower tidal volumes at higher respiratory rates for initial hemodynamic measurements. They will then be transitioned to the higher tidal volume at lower respiratory rate condition for repeat hemodynamic measurement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High transition to Low Vt protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm of the study will begin with higher tidal volumes at lower respiratory rates for initial hemodynamic measurements. They will then be transitioned to the lower tidal volume at higher respiratory rate condition for repeat hemodynamic measurement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Low Vt protocol</intervention_name>
    <description>Low Vt protocol - tidal volumes (Vt) 6 ml/kg, respiratory rate required for end tidal carbon dioxide (EtCO2) of 36-38 mmHg, PEEP 5 centimeter of water (cm-H20) , I:E ratio 1:2</description>
    <arm_group_label>High transition to Low Vt protocol</arm_group_label>
    <arm_group_label>Low transition to High Vt protocol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>High Vt protocol</intervention_name>
    <description>High Vt protocol - tidal volumes (Vt) 10 ml/kg, respiratory rate required for EtCO2 of 36-38 mm Hg, PEEP 5 cmH2O, I:E ratio 1:3.</description>
    <arm_group_label>High transition to Low Vt protocol</arm_group_label>
    <arm_group_label>Low transition to High Vt protocol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients of UPMC Children's Hospital of Pittsburgh that have Fontan physiology (single&#xD;
             heart ventricle) that are presenting as outpatients to undergo a cardiac&#xD;
             catheterization with general endotracheal anesthesia for purpose of diagnosis or&#xD;
             interventional cath.&#xD;
&#xD;
          -  Parents and/or guardians willing to provide informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Those unwilling to give consent and those patients who do not have Fontan physiology.&#xD;
&#xD;
          -  Any urgent/emergent catheterization procedure will be excluded.&#xD;
&#xD;
          -  Any Fontan patient having a cardiac catheterization under monitored anesthesia care&#xD;
             (as opposed to general endotracheal anesthesia) will not be eligible.&#xD;
&#xD;
          -  Inability to undergo cardiac catheterization.&#xD;
&#xD;
          -  Pregnant women will be excluded.&#xD;
&#xD;
          -  &lt; 6 weeks post-op from Fontan completion surgery&#xD;
&#xD;
          -  Same hospitalization as Fontan completion surgery&#xD;
&#xD;
          -  Intrinsic pulmonary disease which would be anticipated to impact study protocol /&#xD;
             findings&#xD;
&#xD;
          -  Fontan completion surgery performed at age &gt; 7 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Phillip S Adams, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Phillip S Adams, DO</last_name>
    <phone>412-692-4503</phone>
    <email>adamsp@upmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bryan Goldstein, MD</last_name>
    <phone>412-692-6903</phone>
    <email>bryan.goldstein@chp.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UPMC Children's Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Adams, DO</last_name>
      <phone>412-692-4503</phone>
      <email>adamsp@upmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>David Groscost, RN</last_name>
      <phone>412-864-8655</phone>
      <email>david.groscost@chp.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Philip Adams, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Shekerdemian LS, Bush A, Shore DF, Lincoln C, Redington AN. Cardiopulmonary interactions after Fontan operations: augmentation of cardiac output using negative pressure ventilation. Circulation. 1997 Dec 2;96(11):3934-42.</citation>
    <PMID>9403618</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 8, 2020</study_first_submitted>
  <study_first_submitted_qc>December 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>March 2, 2021</last_update_submitted>
  <last_update_submitted_qc>March 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Phillip S. Adams, DO</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

